Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-19-071451)

Filing Details

Accession Number:: 0001104659-19-071451
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-10 16:31:00
Reporting Period:: 2019-12-09

Accepted Time:: 2019-12-10 16:31:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1756262	Transmedics Group Inc.	TMDX	Pharmaceutical Preparations (2834)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1082554	United Therapeutics Corp	1040 Spring Street Silver Spring MD 20910		No	No	Yes	No
1774528	Pbc Biotechnology Lung	1040 Spring Street Silver Spring MD 20910		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-09	500,000	$18.75	2,053,240	No	4	S	Indirect	By Lung Biotechnology PBC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Lung Biotechnology PBC

Footnotes

The securities reported as being indirectly beneficially owned by United Therapeutics Corporation are directly beneficially owned by Lung Biotechnology PBC. Lung Biotechnology PBC is a wholly-owned subsidiary of United Therapeutics Corporation.